1. Kellar RS, Hubka M, Rheins LA, Fisher G, Naughton GK. Hypoxic conditioned culture medium from fibroblasts grown under embryonic-like conditions supports healing following post-laser resurfacing. J Cosmet Dermatol. 2009;8(3):190-196.

2. Data on file at SkinMedica®.

You Want to Do All That You Can For Your Skin With SkinMedica®,
You Can.

Work with your skin care professional to maintain and enhance the benefits of your procedure by adding a targeted treatment to your skincare regimen.

REJUVENATION
TNS Essential Serum®
TNS Recovery Complex®
HYDRATION
HA Rejuvenating Hydrator
RADIANCE
The LUMIVIVE® System
BRIGHTENING
Lytera® 2.0 Pigment
Correcting Serum

Earn Points and Save
With Brilliant Distinctions®

The rewards program that helps you save on SkinMedica® and select Allergan products and services.

Register Now

CAUTION: Do not use Retinol Complex if you are pregnant, lactating, or planning to become pregnant. Mild redness, peeling, and irritation are expected when using these products. Use a sunscreen and limit sun exposure while using these products, and for a week following discontinuation.

CAUTION: GlyPro products used together may cause irritation.

Sunburn alert: AHA/BHA Exfoliating Cleanser, AHA/BHA Cream, and all GlyPro products contain an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using these products, and for a week following discontinuation.

IMPORTANT! SUNSCREEN IS REQUIRED TO OPTIMIZE AND MAINTAIN THE RESULTS OF USING LYTERA® 2.0 PIGMENT CORRECTING SERUM.

Most SkinMedica® products are intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These SkinMedica® products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA, and the statements have not been evaluated by the FDA.

SkinMedica® TOTAL DEFENSE + REPAIR Broad Spectrum Sunscreens (SPF 34, SPF 34 Tinted, and SPF 50+) and Essential Defense Broad Spectrum Sunscreens (Everyday Clear SPF 47, Mineral Shield Tinted SPF 32, and Mineral Shield SPF 35) are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 352.

The PA rating system is used in Japan to classify UVA protection and is not an FDA requirement on sunscreens sold in the U.S.

SkinMedica® Acne System, Acne Treatment Lotion, Purifying Foaming Wash, and Purifying Toner are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 333 Subpart D.

Not all products are available in Canada. Subject to change at any time without prior notice.